Inhibition of Tumor Necrosis Factor-α Improves Postischemic Recovery of Hypertrophied Hearts
- 18 September 2001
- journal article
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (suppl 1) , I-350-350
- https://doi.org/10.1161/hc37t1.094851
Abstract
Background Tumor necrosis factor (TNF)-α has been implicated in the pathogenesis of heart failure and ischemia-reperfusion injury. Effects of TNF-α are initiated by membrane receptors coupled to sphingomyelinase signaling and include altered metabolism and calcium cycling, contractile dysfunction, and cell death. We postulate that pressure-overload hypertrophy results in increased myocardial TNF-α expression and that it contributes to decreased contractility in hypertrophied infant hearts subjected to ischemia-reperfusion. Methods and Results Neonatal rabbits underwent aortic banding to induce LV hypertrophy. Myocardial TNF-α protein expression increased progressively with LV hypertrophy. Serum TNF-α was detected only after the onset of heart failure. Before onset of ventricular dilatation and heart failure (determined by serial echocardiograms), hearts from aortic banded and age-matched control rabbits were perfused in the Langendorff mode and subjected to 45 minutes of ischemia and 30 minutes of reperfusion. Postischemic recovery was impaired in hypertrophied hearts, but addition of neutralizing anti-rabbit TNF-α antibody to cardioplegia and perfusate solutions restored postischemic function. This effect was mimicked by treatment with the ceramidase inhibitor N -oleoyl ethanolamine. TNF-α inhibition also was associated with faster postischemic recovery of phosphocreatine, ATP, and pH as assessed by 31P nuclear magnetic resonance spectroscopy. Intracellular calcium handling, measured by Rhod 2 spectrofluorometry, demonstrated lower diastolic calcium levels and higher systolic calcium transients in anti-TNF-α treated hearts. Conclusions TNF-α is expressed in myocardium during compensated pressure-overload hypertrophy and contributes to postischemic myocardial dysfunction. Inhibition of TNF-α signaling significantly improves postischemic contractile function, myocardial energetics, and intracellular calcium handling.Keywords
This publication has 18 references indexed in Scilit:
- Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overloadJournal of the American College of Cardiology, 2000
- Cytokines Increase Neonatal Cardiac Myocyte Calcium Concentrations: The Involvement of Nitric Oxide and Cyclic NucleotidesJournal of Interferon & Cytokine Research, 1999
- Tissue Expression and Immunolocalization of Tumor Necrosis Factor-α in Postinfarction Dysfunctional MyocardiumCirculation, 1999
- Effects of tumour necrosis factor-α on left ventricular function in the rat isolated perfused heart: possible mechanisms for a decline in cardiac functionBritish Journal of Pharmacology, 1999
- Cardiac Failure in Transgenic Mice With Myocardial Expression of Tumor Necrosis Factor-αCirculation, 1998
- Hemodynamic Regulation of Tumor Necrosis Factor-α Gene and Protein Expression in Adult Feline MyocardiumCirculation Research, 1997
- Tumor Necrosis Factor-α Provokes a Hypertrophic Growth Response in Adult Cardiac MyocytesCirculation, 1997
- Sphingosine Mediates the Immediate Negative Inotropic Effects of Tumor Necrosis Factor-α in the Adult Mammalian Cardiac MyocyteJournal of Biological Chemistry, 1997
- Calcium Overload during Reperfusion is Accelerated in Isolated Hypertrophied Rat HeartsJournal of Molecular and Cellular Cardiology, 1994
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990